Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Altimmune Inc
3G0Current price
8.41 EUR
-0.59 EUR (-6.56%)
Last closed
9.52 USD
Company
altimmune.com
ISIN
US02155H2004
Sector
Healthcare
Industry
Biotechnology
Exchange
Frankfurt Exchange
Capitalization
545 825 280 USD
Yield for 12 month
+246.52 %
1Y
3Y
5Y
10Y
15Y
3G0
Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide, a GLP-1/glucagon dual receptor agonist that is in Phase 2 trial for the treatment of obesity and metabolic dysfunction-associated steatohepatitis. It is also developing HepTcell, an immunotherapeutic product candidate, which is in Phase 2 clinical trial for patients chronically infected with the hepatitis B virus. The company was formerly known as Vaxin Inc. and changed its name to Altimmune, Inc. in September 2015. Altimmune, Inc. was founded in 1997 is headquartered in Gaithersburg, Maryland. Address: 910 Clopper Road, Gaithersburg, MD, United States, 20878
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
20.57 USDP/E ratio
–Dividend Yield
–Current Year
+426 000 USD
Last Year
-68 000 USD
Current Quarter
+5 000 USD
Last Quarter
+5 000 USD
Current Year
-51 000 USD
Last Year
-136 000 USD
Current Quarter
-56 000 USD
Last Quarter
-102 000 USD
Key Figures 3G0
1 year
3 years
5 years
10 years
EBITDA
-96 888 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-34.1 %
PEG Ratio
–
Return On Equity TTM
-63.29 %
Wall Street Target Price
20.57 USD
Revenue TTM
409 000 USD
Book Value
2.15 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-16.7 %
Dividend Yield
–
Gross Profit TTM
-70 520 000 USD
Earnings per share
-1.63 USD
Diluted Eps TTM
-1.63 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics 3G0
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 3G0
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
20.01.2017
Forward Annual Dividend Yield
–
Last Split Factor
1:30
Payout Ratio
–
Last Split Date
14.09.2018
Dividend Date
14.09.2018
Stock Valuation 3G0
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
935.8897
Price Sales TTM
1334.5361
Enterprise Value EBITDA
-4.1998
Price Book MRQ
3.5785
Financials 3G0
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators 3G0
For 52 weeks
2.34 USD
14.84 USD
50 Day MA
6.82 USD
Shares Short Prior Month
22 397 958
200 Day MA
7.66 USD
Short Ratio
10.72
Shares Short
22 234 476
Short Percent
31.37 %
BeatStart